πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

52 results for β€œsars-cov-” Clear

  1. TNX-102 SL

    Tonix Pharmaceuticals Holding

    Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection

    phase 2 small molecule completed

    1 trial

  2. Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28

    Sinovac Research and Development Co.,

    COVID-19

    phase 2 mab completed

    1 trial

  3. Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28

    Sinovac Research and Development Co.,

    COVID-19

    phase 2 mab completed

    2 trials

  4. Upamostat

    RedHill Biopharma

    SARS-CoV-2

    phase 2 small molecule completed

    1 trial

  5. VLA2001

    United Therapeutics Europe Ltd

    SARS-CoV-2 Virus Infection

    phase 2 mab completed

    1 trial

  6. low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 mab completed

    1 trial

  7. A Study to Learn About if the Study Medicine Called Ibuzatrelvir changes how the body process the other Medicine Dabigatran Etexilate in healthy adults

    Pfizer Australia Pty Ltd

    severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

    phase 1 other active

    1 trial

  8. COVID-HIG

    United Therapeutics Europe Ltd

    SARS-CoV-2 Infection

    phase 1 mab completed

    1 trial

  9. EDP-235

    ENANTA PHARMACEUTICALS INC

    SARS CoV 2 Infection

    phase 1 small molecule completed

    1 trial

  10. GB-0669

    Generate Biomedicines

    SARS CoV-2

    phase 1 small molecule completed

    1 trial

  11. INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 ΞΌg

    Hospital Authority, Hong Kong

    COVID-19 Pandemic

    phase 1 mab active

    1 trial

  12. Recombinant SARS-CoV-2 Fusion Protein Vaccine

    Livzon Pharmaceutical Group

    COVID19

    phase 1 mab completed

    1 trial

  13. TNX-2110

    Tonix Pharmaceuticals Holding

    Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2

    phase 1 mab terminated

    1 trial

  14. Two doses of middle-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 28

    Jiangsu Province Centers for Disease Control and Prevention

    COVID-19

    phase 1 mab completed

    1 trial

  15. Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 Β΅g

    Hospital Authority, Hong Kong

    COVID-19 Pandemic

    phase 1 mab active

    1 trial

  16. randomized, double-blinded, placebo-controlled

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prevention of COVID-19 Caused by SARS-CoV-2

    phase 1 mab active

    1 trial

  17. AZD1222

    AstraZeneca

    COVID-19, SARS-CoV-2

    approved mab terminated

    1 trial

  18. High-dosage SARS-CoV-2 vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  19. Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  20. Inactivated SARS-CoV-2 Vaccine (Vero cellοΌ‰

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  21. Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SARS-CoV-2 Infection

    approved mab active

    1 trial

  22. SARS-CoV-2 Inactivated Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    2 trials

  23. Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

    Moderna Biotech Spain

    SARS-CoV-2 infection

    approved small molecule active

    1 trial

  24. Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources